Antinucleic Acid Antibodies

Overview

Journal J Clin Pathol Suppl (R Coll Pathol)

Specialty Pathology

Date 1979 Jan 1

PMID 93113

Authors

E J HOLBOROW

Affiliations

Soon will be listed here.

References

Arden L, Lakmaker F, FELTKAMP T . Immunology of DNA. II. The effect of size and structure of the antigen on the Farr assay. J Immunol Methods. 1976; 10(1):39-48. DOI: 10.1016/0022-1759(76)90005-3. View

FARBER S, BOLE G . Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients. Arch Intern Med. 1976; 136(4):425-31. View

Aslpaugh M, Tan E . Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence. Arthritis Rheum. 1976; 19(4):711-9. DOI: 10.1002/1529-0131(197607/08)19:4<711::aid-art1780190409>3.0.co;2-i. View

Sharp G, Irvin W, May C, HOLMAN H, MCDUFFIE F, Hess E . Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med. 1976; 295(21):1149-54. DOI: 10.1056/NEJM197611182952101. View

HOLMAN H, KUNKEL H . Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science. 1957; 126(3265):162-3. DOI: 10.1126/science.126.3265.162. View

HOLBOROW E, WEIR D, JOHNSON G . A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J. 1957; 2(5047):732-4. PMC: 1962253. DOI: 10.1136/bmj.2.5047.732. View

ROBBINS W, HOLMAN H, Deicher H, KUNKEL H . Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med. 1957; 96(3):575-9. DOI: 10.3181/00379727-96-23545. View

HOLMAN H, DEICHER H, KUNKEL H . The L. E. cell and the L. E. serum factors. Bull N Y Acad Med. 1959; 35(7):409-18. PMC: 1806184. View

BECK J . Variations in the morphological patterns of "autoimmune" nuclear fluorescence. Lancet. 1961; 1(7188):1203-5. DOI: 10.1016/s0140-6736(61)91944-4. View

10.

Locker J, Medof M, Bennett R, Sukhupunyaraksa S . Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states. J Immunol. 1977; 118(2):694-701. View

11.

Lange A . Evaluation of the simultaneous estimation of anti-dsDNA and anti-ssDNA antibodies for clinical purposes. Clin Exp Immunol. 1978; 31(3):472-81. PMC: 1541258. View

12.

Cohen M, Dawkins B, Dawkins R, Owen E . Clinical significance of antibodies to ribonucleoprotein. Ann Rheum Dis. 1979; 38(1):74-8. PMC: 1000324. DOI: 10.1136/ard.38.1.74. View

13.

Wolfe J, Adelstein E, Sharp G . Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest. 1977; 59(1):176-8. PMC: 333345. DOI: 10.1172/JCI108616. View

14.

Chubick A, Sontheimer R, Gilliam J, ZIFF M . An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay. Ann Intern Med. 1978; 89(2):186-92. DOI: 10.7326/0003-4819-89-2-186. View

15.

Miyawaki S, Kohmoto K, Kurata N, OFUJI T . Identification and characterization of two new soluble nuclear antigens reactive with sera of patients with connective tissue diseases. Arthritis Rheum. 1978; 21(7):803-10. DOI: 10.1002/art.1780210711. View

16.

Barnett E . Anti-DNA antibodies: perspectives and perplexities. J Immunol Methods. 1979; 27(1):1-7. DOI: 10.1016/0022-1759(79)90233-3. View

17.

Koffler D, Schur P, KUNKEL H . Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967; 126(4):607-24. PMC: 2138388. DOI: 10.1084/jem.126.4.607. View

18.

Pinnas J, NORTHWAY J, Tan E . Antinucleolar antibodies in human sera. J Immunol. 1973; 111(4):996-1004. View

19.

Mattioli M, Reichlin M . Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J Immunol. 1971; 107(5):1281-90. View

20.

BLOMGREN S, CONDEMI J, Vaughan J . Procainamide-induced lupus erythematosus. Clinical and laboratory observations. Am J Med. 1972; 52(3):338-48. DOI: 10.1016/0002-9343(72)90021-6. View